Results from the PATHFINDER 2 trial of Grail's blood test for multiple cancers have shown greater efficacy and a lower rate of false alarms than in an earlier trial of the technology. The Galleri ...
Space is part of Future US Inc, an international media group and leading digital publisher. Visit our corporate site.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results